noscript

News and Announcements

Anteo Signs Licensing Agreement

  • Published March 13, 2012 12:14AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

13th March 2012 Companys Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000 Anteo signs licensing agreement with leading Life Science Company Agreement for the licensing of MixampGo technology with eBioscience Licensing arrangement for all global markets eBioscience operates in 70 countries and a recognised leader in Life Science reagents Agreement moves MixampGo up value chain to test manufacturers Healthy pipeline of potential commercial agreements 13 March 2012: Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has signed a Patent and Technology License Agreement with eBioscience, a leading US headquartered Life Sciences company, providing them with access to Anteos unique MixampGo technology.

—–

To view the full article, please click here.

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now